Neonatal hyperbilirubinemia is the most common reason for hospital readmiss
ion in the first 2 weeks of life. Kernicterus is still relatively uncommon
but has been on the rise with the institution in the 1990s of aggressive ea
rly postnatal discharge policies. Bilirubin-induced complications can be pr
evented by instituting a neonatal jaundice protocol to identify infants at
risk for significant hyperbilirubinemia, by ensuring adequate parental educ
ation and preparedness, and by implementing a good neonatal tracking system
for follow-up care. Hyperbilirubinemia is easily treated with phototherapy
, which can be administered at home in selected infants.